The main reason for the poor effect of hepatitis B treatment is mis-treatment, chaotic treatment, failure of treatment, specifically the following seven points: 1, inappropriate choice of treatment object. Many patients do not belong to the scope of antiviral treatment, such as chronic viral carriers, patients with cirrhosis in the middle and late stages, but they are hard to use interferon and other antiviral drug treatment. The result is not only difficult to achieve therapeutic effect, but also easy to cause adverse reactions. 2. Incorrect medication program. Although some patients belong to the scope of antiviral treatment, but the selected antiviral drugs, their dosage and treatment program are incorrect, and it is difficult to be effective in the clinic. For example, the appropriate dosage of a-interferon for hepatitis B patients in China should be 5 million to 10 million units, and the course of treatment should be half a year to one year, but very few patients are treated accordingly. Although lamivudine (Herceptin) has the advantage of rapid inhibition of the virus, but the need for long-term uninterrupted use of medication, some patients use the process, without the permission of the doctor, stopping the drug without authorization, resulting in “lamivudine (Herceptin) stopping hepatitis”, the liver function is abnormal again, the viral index of the results of the positive. 3.Misuse or indiscriminate use of drugs. Some patients go around seeking medical treatment, today with western medicine, tomorrow with traditional Chinese medicine; a wide range of false liver disease advertisements more so that the majority of patients are at a loss. Most of the hepatitis B advertising drugs are false and deceptive, the efficacy of all-encompassing, God, luring patients hooked, cheating money. Abuse or indiscriminate use of these advertisements can only make hepatitis B patients worse, the consequences are even worse. 4, should not be treated also desperately treatment. China’s hepatitis B infection, but the vast majority of chronic hepatitis B virus carriers, most of them do not have special discomfort, normal liver function, hepatitis B virus replication index negative, these people should not be treated with medication, no matter how to use the drug, but also difficult to change the results of surface antigen positive. These people can still be regarded as normal people and can engage in normal work and study. Unfortunately, many of these people are trying all kinds of treatment, trying to make the surface antigen negative, in order to completely change the negative impact of surface antigen positive. 5.Treatment goal orientation deviation. At present, the best goal and result of hepatitis B treatment is: long-term stabilization and normalization of liver function and keeping negative viral replication index. The treatment goal should not be set too high, and it is absolutely impossible to pursue surface antigen negative, or the so-called “triple positive” all negative. However, many hepatitis B patients and even hepatitis B virus carriers are spending money on treatment for this illusory goal, so it is no wonder that the goal cannot be reached even after treatment. 6, lose the best time for treatment. The best time to treat hepatitis B is the patients with mildly elevated aminotransferase and positive hepatitis B virus replication index, the shorter the duration of the disease, the better the treatment effect. Some patients have hepatitis B, not timely treatment, still drink, do not pay attention to rest, the condition into the cirrhosis stage before the urgent treatment, the treatment effect is naturally poor. 7, psychological state and psychological regulation imbalance. Hepatitis B, every day anxiety, panic, life and work quality decline, over time, autoimmune dysfunction, but exacerbated the condition.